Disease modifying treatments for Alzheimer's disease: Clinician perspectives

Read full text Summarise with VIRAT
Authors: Catherine M. Pennington, Prathima Apurva, Ailin Chen, Alan Duncan, Graham Andrew Mackay, Hugh Masters, Katherine Paramore, Tom C. Russ, Helen Skinner, Martin Zeidler
Cited by: 0
References: 34

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

In recent years there have been exciting developments in the diagnosis and treatment of mild cognitive impairment and dementia due to Alzheimer's disease. Robust biomarkers and potentially disease modifying therapies are now available, with multiple other agents in clinical trials alongside on-going validation studies of blood-based biomarkers. Recent and probable future developments in the diagnosis and care of people with Alzheimer's disease pathology warrants serious re-evaluation of the structure and function of cognitive clinical services. Here we report recommendations from the November 2024 Brain Health Scotland roundtable discussion of opportunities and challenges for modern memory services.

Fields of Study & Subjects

Dementia and Cognitive Impairment Research Alzheimer's disease research and treatments Cancer-related cognitive impairment studies

Publication details

Journal / source
Journal of Alzheimer s Disease
Volume
111
Issue
1
Pages
125–131
Publication date
25 March 2026
Language
EN